Volume 1 - Supplement Issue 1: Abstracts of International Tehran Breast Cancer Congress                   Multidiscip Cancer Investig 2017, 1 - Supplement Issue 1: Abstracts of International Tehran Breast Cancer Congress: 0-0 | Back to browse issues page

XML Print

Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Akrami M, Tahmasebi S, Zangouri V, Hosseini S, Talei A. Metastatic Behavior of Breast Cancer Subtypes. Multidiscip Cancer Investig. 2017; 1
URL: http://mcijournal.com/article-1-165-en.html
Abstract:   (1624 Views)
Introduction: Invasive ductal carcinoma (IDC) is the most common form of breast cancer, including 80 percent of all breast cancer diagnoses. The objective of our retrospective cohort study was to investigate patterns of subtype-specific metastatic spread in these patients.
Materials and Methods: Patients with IDC referred to Breast Diseases Research Center affiliated with Shiraz University of Medical Sciences, and diagnosed between the years 1993 and 2017 were included. Statistical analysis was performed via SPSS Statistics for Windows, Version 21.
Results: Mean follow-up time among 4674 eligible patients was 46 months (range 0-277 months). The longest Distant Metastasis Free Survival (DMFS) time was observed in the Luminal B subtype (mean 194 months) whereas the shortest was observed in the Triple Negative Breast Cancer (TNBC) subtype (mean 129 months, P=0.006).The lowest DMFS rate pertained to TNBC tumors (73.8%). Luminal A-associated metastases were found to be solitary in 83.1% of cases, whereas HER2+ tumors showed multi-organ relapses in 30.5% of cases. Luminal A and B tumors expressed a preference for bone metastasis (55.3% vs. 36.5) while HER2+ and TNBC cases showed liver (40.7%) and lung (36.4%) metastasis, respectively, as the most common site of metastasis.
Conclusions: These findings further represent that breast tumor subtypes differ not only
in tumor characteristics but also in their metastatic behavior. TNBC tumors featured the most aggressive clinical course. Further identification of subtype-specific factors influencing prognosis might have an impact on appropriate strategy for follow-up of newly diagnosed IDC breast cancer patients.
Full-Text [PDF 61 kb]   (457 Downloads)    
Type of Study: Original/Research Article | Subject: diagnosis
Received: 2017/10/31 | Accepted: 2017/10/31 | ePublished: 2017/10/31

Add your comments about this article : Your username or Email:

© 2019 All Rights Reserved | Multidisciplinary Cancer Investigation

Designed & Developed by : Yektaweb